AGP Executive Report
Last update: 19 minutes agoRegulation Watch (US/VA): Virginia’s Cannabis Control Authority released draft rules for its recreational market, including retail store license fees (a $4,000 application fee plus a $20,000 first-year authorization, then $15,000 renewals) and microbusiness licensing costs aimed at smaller operators. Market Update (Minnesota): Minnesota’s adult-use market turned 1 year old with about $150M in adult-use sales and over $250M total including medical, while new cultivation licenses are expected to expand supply and ease prices in the coming months. Safety/Impairment: A new study reports cannabis edibles can impair simulated driving performance for hours even when blood THC is below common roadside enforcement limits, raising questions about how impairment is measured. Recall (Missouri): Missouri regulators issued a recall for mold-positive infused pre-rolls after routine testing found Aspergillus; consumers are told to stop using and return unused product. Enforcement/Legal: Idaho voters will decide whether to shift drug-law legalization authority from citizen initiatives to the state legislature via a constitutional amendment. Industry/Stocks (ASX): Traders are watching medicinal cannabis and hemp/CBD names including MGC Pharmaceuticals, Cann Group, Little Green Pharma, Zelira Therapeutics, and Elixinol Wellness after fresh company updates.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
